Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa
- PMID: 20079931
- DOI: 10.1016/j.ophtha.2009.09.056
Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa
Abstract
Purpose: To correlate visual acuity of patients with Leber's congenital amaurosis (LCA) and early childhood-onset retinitis pigmentosa (RP) with mutations in underlying LCA genes.
Design: Multicentered retrospective observational study.
Participants: After exclusion of 28 subjects, 169 patients with the diagnosis of LCA and 27 patients with early childhood-onset RP were included in the study because the underlying mutations in AIPL1, GUCY2D, RDH12, RPE65, CRX, CRB1, RPGRIP1, CEP290, LCA5, and TULP1 genes could be identified in this cohort of patients.
Methods: We collected data on best-corrected visual acuity as recorded at the time of the patient's most recent visit to one of the participating ophthalmology departments. The median and range of visual acuities for each genetic subtype were calculated separately for the LCA and early childhood-onset RP groups.
Main outcome measures: The range and median best-corrected visual acuities for each genetic subtype and age-related mean visual acuities for each genetic subtype.
Results: A wide variation in visual acuity was observed in patients with LCA and RPE65, RDH12, and CRB1 mutations, whereas AIPL1, GUCY2D, CRX, and RPGRIP1 gene mutations were associated with severely decreased visual acuities beginning within the first year of life. It was also noted that patients with either an RPE65 or CRB1 mutation have progressive visual loss with advancing age. Onset of visual symptoms after infancy was associated with a relatively better visual prognosis.
Conclusions: The data obtained from this study will help clinicians provide counseling on visual prognosis to patients with known mutations in LCA genes and be of value in future studies aimed at the treatment of LCA and early childhood-onset RP.
Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Evaluation of genotype-phenotype associations in leber congenital amaurosis.Retina. 2005 Oct-Nov;25(7):919-29. doi: 10.1097/00006982-200510000-00016. Retina. 2005. PMID: 16205573
-
Identification of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis pigmentosa.J Med Genet. 2005 Nov;42(11):e67. doi: 10.1136/jmg.2005.035121. J Med Genet. 2005. PMID: 16272259 Free PMC article.
-
Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort.Int J Mol Sci. 2023 May 17;24(10):8915. doi: 10.3390/ijms24108915. Int J Mol Sci. 2023. PMID: 37240262 Free PMC article.
-
Leber Congenital Amaurosis – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.2004 Jul 7 [updated 2013 May 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2004 Jul 7 [updated 2013 May 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301475 Free Books & Documents. Review.
-
Leber Congenital Amaurosis.Adv Exp Med Biol. 2018;1085:131-137. doi: 10.1007/978-3-319-95046-4_26. Adv Exp Med Biol. 2018. PMID: 30578499 Review.
Cited by
-
Pseudo-fovea formation after gene therapy for RPE65-LCA.Invest Ophthalmol Vis Sci. 2014 Dec 23;56(1):526-37. doi: 10.1167/iovs.14-15895. Invest Ophthalmol Vis Sci. 2014. PMID: 25537204 Free PMC article. Clinical Trial.
-
Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients.Mol Vis. 2012;18:744-50. Epub 2012 Mar 28. Mol Vis. 2012. PMID: 22509104 Free PMC article.
-
Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.Invest Ophthalmol Vis Sci. 2011 Aug 29;52(9):6898-910. doi: 10.1167/iovs.11-7701. Invest Ophthalmol Vis Sci. 2011. PMID: 21757580 Free PMC article.
-
Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report.Nat Med. 2021 May;27(5):785-789. doi: 10.1038/s41591-021-01297-7. Epub 2021 Apr 1. Nat Med. 2021. PMID: 33795869 Free PMC article.
-
Natural History and Genotype-Phenotype Correlations in RDH12-Associated Retinal Degeneration.Adv Exp Med Biol. 2019;1185:209-213. doi: 10.1007/978-3-030-27378-1_34. Adv Exp Med Biol. 2019. PMID: 31884613 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials